Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Lacy B, Ayyagari R, Guerin A, Lopez A, Shi S, Luo M. Factors associated with more frequent diagnostic tests and procedures in patients with irritable bowel syndrome. Therap Adv Gastroenterol. 2019;1:17.
2. Tack J, Stanghellini V, Mearin F et al. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterol 2019;19:69.
3. Haag S, Senf W, Tagay S, Langkafel M, Braun-Lang U, Pietsch A, Heuft G, Talley NJ, Holtmann G. Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther. 2007;25:973–986.
4. Koloski N, Shah A, Kaan I et al. Healthcare utilisation patterns: irritable bowel syndrome, inflammatory bowel disease and gastroesophageal reflux disease. Dig Dis Sci. 2024. https://doi.org/10.1007/s10620-024-08297-w.
5. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;S0016–5085:00222–00225.